Cargando…

Galcanezumab for migraine

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450771/
https://www.ncbi.nlm.nih.gov/pubmed/32921891
http://dx.doi.org/10.18773/austprescr.2020.044
_version_ 1783574859999084544
collection PubMed
description
format Online
Article
Text
id pubmed-7450771
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-74507712020-09-11 Galcanezumab for migraine Aust Prescr New Drugs NPS MedicineWise 2020-06-25 2020-08 /pmc/articles/PMC7450771/ /pubmed/32921891 http://dx.doi.org/10.18773/austprescr.2020.044 Text en (c) https://creativecommons.org/licenses/by-sa/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution ShareAlike (CC BY-SA) 4.0 License.
spellingShingle New Drugs
Galcanezumab for migraine
title Galcanezumab for migraine
title_full Galcanezumab for migraine
title_fullStr Galcanezumab for migraine
title_full_unstemmed Galcanezumab for migraine
title_short Galcanezumab for migraine
title_sort galcanezumab for migraine
topic New Drugs
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450771/
https://www.ncbi.nlm.nih.gov/pubmed/32921891
http://dx.doi.org/10.18773/austprescr.2020.044